MENU
+Compare
IMNM
Stock ticker: NASDAQ
AS OF
Jun 20 closing price
Price
$8.75
Change
-$0.08 (-0.91%)
Capitalization
761.36M

IMNM Immunome Forecast, Technical & Fundamental Analysis

Immunome Inc is a biopharmaceutical company... Show more

IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMNM with price predictions
Jun 20, 2025

IMNM sees MACD Histogram just turned negative

IMNM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 17, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IMNM moved out of overbought territory on June 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IMNM as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMNM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMNM advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 141 cases where IMNM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.479) is normal, around the industry mean (16.327). P/E Ratio (0.000) is within average values for comparable stocks, (59.143). IMNM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.273). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (52.356) is also within normal values, averaging (251.148).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMNM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMNM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IMNM is expected to report earnings to -52 cents per share on August 13

Immunome IMNM Stock Earnings Reports
Q2'25
Est.
$-0.52
Q1'25
Beat
by $0.14
Q4'24
Missed
by $0.45
Q3'24
Missed
by $0.24
Q2'24
Missed
by $0.22
The last earnings report on May 12 showed earnings per share of -51 cents, beating the estimate of -66 cents. With 1.32M shares outstanding, the current market capitalization sits at 761.36M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTUTX57.900.12
+0.21%
Fidelity Advisor Telecommunications M
CZMSX15.16-0.04
-0.26%
Multi-Manager Small Cap Eq Strat Inst
DGLYX20.69-0.11
-0.53%
BNY Mellon Global Stock - Y
DISVX26.99-0.16
-0.59%
DFA International Small Cap Value I
UNWPX2.06-0.02
-0.96%
US Global Investors World Prec Mnral

IMNM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.91%
IDYA - IMNM
61%
Loosely correlated
-0.87%
SYRE - IMNM
56%
Loosely correlated
-0.46%
BEAM - IMNM
54%
Loosely correlated
-1.35%
RXRX - IMNM
54%
Loosely correlated
-1.57%
ARWR - IMNM
53%
Loosely correlated
-1.92%
More